Boldt S.A (BOLT) Fair Value & Analysis
Healthcare · AR · Market cap 24.2M ILA
Fair value as of: Jun 25, 2026
Analysis
Boldt S.A (BOLT) currently trades at 3.70 ILA, while our model-based Fair Value estimate is 1.81 ILA — implying the stock looks roughly 51.1% overvalued today. We read business quality at 80/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
Boldt S.A. engages in the administration, management, exploitation, and operation of casinos and electronic gambling machines in Argentina. It operates through five segments Data processing, Real estate sales, Communications, Entertainment, and Rentals. The company offers telecommunications services; services linked to supply, data processing, maintenance, development, and implementation of software linked to slot machines; and rental of corporate towers and shopping malls. In addition, it is involved in the entertainment, hotel, and related machines; printing of documentation referring to the identification of people and goods; management and conservation of cadastres; gastronomy; cars and vehicle storage; and exploitation and/or marketing of real estate, as well as construction and engineering works. Boldt S.A. was incorporated in 1943 and is based in Buenos Aires, Argentina.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Boldt S.A (BOLT) undervalued?
What is the fair value of BOLT?
What is the quality score of BOLT?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.